Zentiva Looks To Shore Up Sales

Falling revenues in the home market and in Romania could force Czech drugmaker Zentiva to change its tactics in Central & Eastern Europe. BMI believes this could include altering its distribution practices in Romania and increasing its presence in Russia and the CIS in order to make up for the difficult domestic environment.

To read the full article, please choose one of the following options: